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Background: Most studies on sepsis were conducted in developed countries. The aim of this study is to report on
a series of patients with sepsis in a tertiary hospital in a developing country.
Methods: Patients admitted through the emergency department of a single university-based institution between
January 2008 and June 2012, with a final diagnosis of sepsis, bacteremia, or septic shock, were retrieved. A sample
of 97 patients was selected. Vital signs at presentation, number of SIRS criteria, use of vasopressors and steroids, and
in-hospital mortality were recorded.
Results: The mean age was 70.09 ± 16.82, ranging from 19 to 96 years; 48.5 % were females and 51.5 % were males;
42.3 % of the patients were found to be bacteremic. IV fluid requirement during the first 6 h was 1.75 ± 1.96 l. The time
for antibiotic initiation was 3.43 ± 4.48 h, with 87.6 % of the antibiotics initiated in the emergency department.
Norepinephrine was the most commonly used vasopressor (38.1 %) followed by dopamine (8.2 %), and the inotrope
dobutamine (4.1 %); 45.3 % of the patients were admitted to the intensive care unit (ICU), and the remaining 54.7 %
were managed on the general practice unit (GPU). A total of 30 (30.9 %) septic patients died. The 28-day mortality was
20.6 %. Deceased patients had greater vasopressor use, a longer stay in the ICU (p = 0.001), and a longer time to
norepinephrine use (p = 0.004).
Conclusions: This is the first study providing an in-depth analysis of sepsis patients in a developing country, looking at
in-hospital mortality, SIRS criteria utility, and at the overall sepsis management.Background
Sepsis has gained worldwide recognition in the last two
decades. The Early Goal-Directed Therapy (EGDT)
study introduced protocol-based care in sepsis manage-
ment in 2001 [1], followed by the Surviving Sepsis Cam-
paign (SSC) in 2002 [2], to the NIH-funded PROCESS
and ARISE trials that looked at the value of such
protocol-based intervention [3, 4]. Despite the enormous
amount of sepsis research, the incidence of affected pa-
tients in the USA has doubled in the past decade, and
approximately 750,000 persons are affected annually [5],
with one septic patient presenting to an emergency de-
partment in the USA every minute [6]. Most sepsis stud-
ies, whether evaluating the overall mortality of the
disease or the benefit of a specific treatment modality,
were done in developed countries such as the USA,* Correspondence: rb94@aub.edu.lb
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sepsis, the value of SIRS criteria, or its related mortality
in a developing country. The aim of this study is to de-
scribe the pathogens, underlying medical conditions,
management, and mortality of patients presenting with
sepsis at the American University of Beirut Medical Cen-
ter (AUBMC), a 420-bed teaching hospital in Lebanon.Methods
A separate study at our institution looked at sepsis in
dialysis patients and looked at their in-hospital mortality.
There were a total of 97 end-stage renal disease (ESRD)
patients. The non-ESRD patient control group was sig-
nificantly larger. A convenience sample of 97 patients
admitted through the Emergency Department of a single
university-based institution between January 2008 and
June 2012, with a final diagnosis of sepsis, bacteremia, or
septic shock, was randomly selected with the help of a
computer-generated program. Exclusion criteria included
age less than 18 years, pregnant, and trauma cases. Afterticle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Table 1 Baseline characteristics of the patients




Chronic coexisting conditions (%)
Hypertension 58.8
Diabetes 34
Coronary artery disease 25.8
Congestive heart failure 16.9
Chronic obstructive lung disease or emphysema 10.3
Neurologic disease 3.1
SIRS criteria at presentation (%)
2 or more 67
Less than 2 30
Vital signs upon presentation
Temperature (°C) 37.55 ± 1.127
Systolic blood pressure (mmHg) 111.23 ± 27.63
Diastolic blood pressure (mmHg) 60.81 ± 16.91
Mean arterial pressure (mmHg) 77.27 ± 18.96
Heart rate (beats/min) 100.43 ± 28.67
Respiratory rate (respiration/min) 22.31 ± 6.25
Oxygen saturation (%) 94.07 ± 6.7
Baseline laboratory values
White cell count (per mm3) 19.5 ± 3.34 × 10,000
Hemoglobin 10.69 ± 2.45
Hematocrit 32.27 ± 8.43
Lactate (mmol/l) 3.80 ± 3.531
Creatinine (mg/dl) 1.86 ± 1.9
Blood urea nitrogen (mg/dl) 37.03 ± 26.29
Total bilirubin (mg/dl) 3.08 ± 5.2
Partial pressure of carbon dioxide (mmHg) 36.42 ± 10.8
pH arterial blood 7.36 ± 0.13
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American University of Beirut, we studied that same co-
hort of patients and looked at a variety of parameters re-
lated to their emergency department (ED) management,
disposition, and outcome.
Age, gender, ethnicity, and history of comorbidities
were obtained from the patients’ medical record. Pa-
tients’ vital signs and number of SIRS criteria were col-
lected at initial presentation to the emergency department.
The site of infection, causative microorganism, and pres-
ence of bacteremia were retrieved as well as complete
blood count, electrolytes, lactate, cardiac enzymes, arterial
blood gas results, and coagulation profile results. Time to
antibiotics and amount of fluid resuscitation within the first
6 and 24 h, duration and type of vasopressors, and steroids
administration were also noted. Disposition from the ED,
length of stay in ED, intensive care unit (ICU), or general
floor, was calculated. We also looked at hospital mortality
as well as 28-day mortality.
Statistical analysis
A two-tailed sample t test compared lengths of stay in
ED, ICU, or floor; overall length of stay in hospital; time
to and duration of vasopressors, antibiotics, and steroids;
fluid replacement at 6 and 24 h, and vital signs at pres-
entation and after 6 h, between deceased patients and
non-deceased. A Pearson’s chi-square test was used to
compare differences in distribution of bacteremia, ED
disposition, use of vasopressors or steroids, and number
of SIRS criteria at presentation between deceased pa-
tients and non-deceased. Statistical analyses were per-
formed using SPSS Statistics for Windows Version 21.0.
(Armonk, NY: IBM Corp).
Results
Patient characteristics
The mean age was 70.09 ± 16.82, ranging from 19 to
96 years; 48.5 % were females and 51.5 % were males.
The most common underlying comorbidity was hyper-
tension (58.8 %) followed by diabetes (34.0 %) and cor-
onary artery disease (25.8 %) (Table 1). There was no
significant difference in comorbidity distribution be-
tween patients presenting with a systolic blood pressure
less or more than 90 mmHg. Systolic blood pressure
upon presentation to the emergency department ranged
from 53 to 180 mmHg, while it ranged from 66 to
177 mmHg after 6 h of presentation.
Microbiology
Bacteremia was defined as a single positive blood culture
showing non-skin flora pathogens or a minimum of two
positive blood culture bottles with skin flora pathogens;
42.3 % of the patients were found to be bacteremic. The
most common sites of infection were genitourinary
Table 2 Causative microorganisms
Microbiology N (%)a
Escherichia coli 37 (38.1)
Klebsiella pneumoniae 11 (11.3)
Coagulase-negative staphylococci 8 (8.2)
Pseudomonas aeruginosa 7 (7.2)
Enterococcus species 6 (6.2)
Candida species 6 (6.2)
Non-albicans Candida 4 (4.1)
Proteus mirabilis 3 (3.1)
Diphtheroids species 3 (3.1)
Acinetobacter baumannii 2 (2.1)
Streptococcus pneumoniae 2 (2.1)
Others Clostridium species, Listeria monocytogenes,
Morganella morganii, Brucella species,
Providencia alcaligenes
11 (11.3)
aMore than one organism may be retrieved from a single subject
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mentary (10.3 %). In 19.6 % of cases, no focus of infec-
tion could be identified (Table 1). In 76 out of 97
patients (78.4 %), a microorganism was identified with
Gram-negative organisms exceeding the Gram-positives.
Among the Gram-negative organisms, Escherichia coli has
been consistently the most commonly isolated organism
(38.1 %) followed by Klebsiella (11.3 %) and Pseudomonas
(7.2 %). In the Gram-positive bacteremia group, coagulase-
negative staphylococci represented the majority of the iso-
lates (8.2 %) (Table 2). When stratified according to blood
pressure, 38.5 % of patients with systolic blood pressureTable 3 Patient management characteristics
LOS in ED (hours)
LOS in ICU (days)
LOS in GPU (days)
LOS in the hospital (days)
Time to vasopressors in the first 24 h (hours)
Time to norepinephrine (hours)a
Time to dopamine (hours)a
Time to dobutamine (hours)
Vasopressors Tx duration (days) for those who took vasopressors in the first 2
Steroid Tx duration (days)
Time to antibiotic treatment initiation (hours)a
IV fluid requirement first 6 h (liters)
IV fluid requirement first 24 h (liters)
aThe time to norepinephrine, to dopamine, and to antibiotic treatment for one pati
patient’s chartless than 90 mmHg were bacteremic in contrast to 43.5 %
of patients with a systolic blood pressure greater than
90 mmHg.Management
IV fluid requirement during the first 6 h was 1.75 ±
1.96 l and 3.37 ± 2.85 during the first 24 h. On the other
hand, the time for antibiotic initiation was 3.43 ± 4.48 h,
with 87.6 % of the antibiotics initiated in the emergency
department (Table 3).
The time to initiate vasopressors was 9.14 ± 8.03 h.
Norepinephrine was the most commonly used vasopres-
sor (38.1 %) followed by dopamine (8.2 %) and the ino-
trope dobutamine (4.1 %). Vasopressor treatment duration
in the first 24 h was 3.33 ± 3.411 h. Furthermore, the
hypotensive group at presentation required more vasopres-
sors than those who presented with systolic BP ≥90 mmHg.
There was no difference in SIRS criteria between the
hypotensive and normotensive group as 69 % of patients
in both groups had greater than 2 SIRS criteria.Disposition
Admitted to the ICU were 45.3 % of the patients, and
the remaining 54.7 % were managed on the general prac-
tice unit (GPU) (Table 4). The mean length of stay in
the ED was 13.35 ± 17.15 h, while it was 12.04 ± 13.95
and 7.27 ± 5.94 days in the ICU and GPU, respectively.
The mean length of stay in the hospital was 13.86 ±
13.62 days (Table 3); 73.1 % of patients with initial sys-
tolic blood pressure less than 90 mmHg were admitted
to the ICU.Number Mean ± SD Range
97 13.35 ± 17.154 1.00–137.50
43 12.04 ± 13.951 0.40–70.67
52 7.27 ± 5.941 0.33–30.95
97 13.86 ± 13.618 0.507–70.917
21 9.14 ± 8.027 0.50–24.00
36 148.20 ± 282.190 1–1464.00
7 278.31 ± 393.557 1–870.50
4 59.50 ± 41.026 22–114.50
4 h 21 3.33 ± 3.411 0.13–12.88
47 7.55 ± 7.540 0.50–35.00
96 3.43 ± 4.479 0.167–36.33
96 1.75 ± 1.964 0.02–11.06
96 3.37 ± 2.846 0.160–16.642
ent is missing since the paper containing this information was not found in the





Hospital mortality 30 30.9




aTwo patients have not been admitted as one of them left AMA and the other
one died in the ED
Dagher et al. International Journal of Emergency Medicine  (2015) 8:19 Page 4 of 6Mortality
A total of 30 (30.9 %) septic patients died. The 28-day
mortality was 20.6 % with 19.6 % lost to follow-up.
There was no statistically significant difference in hos-
pital mortality between the hypotensive and normoten-
sive groups. There was no significant difference in mean
age, gender distribution, and comorbidities between the
discharged and deceased group. The percentage of
bacteremia was significantly higher in the survival group
(92.7 %) than in the deceased group (7.3 %).
Deceased patients had greater vasopressor use and
a longer stay in the ICU (p = 0.001). Time to norepin-
ephrine was significantly longer in the deceased group
(p = 0.004) (Table 5).
Vital signs upon presentation and after 6 h, IV fluids
requirements during the first 6 and 24 h, and time to
initiation of antibiotics were not different between the
two groups. Out of 30 patients who presented initially
with less than 2 SIRS criteria, 8 died during theirTable 5 Patient mortality characteristics
Mortality (no) Mortality (yes)
p value
N % N %
Norepinephrine 17 45.9 20 54.1 <0.001
Dopamine 3 37.5 5 62.5 0.044
Steroid use 25 53.2 22 46.8 0.001
Antibiotics initiated in ED 61 71.8 24 28.2 0.127
Antibiotics initiated in ICU 2 33.3 4 66.7 0.248
Antibiotics initiated in GPU 4 53.2 2 46.8 0.248
SIRS
0 or 1 22 73.3 8 26.7 0.543
≥ 2 45 67.2 22 32.8
Bacteremia
No 29 51.8 27 48.2 <0.001
Yes 38 92.7 3 7.3
ICU admission 24 55.8 19 44.2 0.012
GPU admission 42 80.8 10 19.2 0.007hospital stay (26.7 %) (Table 5). Laboratory findings also
were not significantly different between the two groups.
Discussion
Since EGDT was published, there has been a steady de-
cline in sepsis-related mortality. The rate of hospitaliza-
tions however has doubled during the past decade in the
USA [7]. Although much of the therapy for severe sepsis
occurs in ICU, as many as 500,000 cases of severe sepsis
are initially managed in EDs annually, with an average
ED length of stay of 5 h [5, 6, 8]. Recent research has
shown that the most important and the cornerstone of
sepsis therapy is early recognition, aggressive fluid hy-
dration and early antibiotics [3, 4]. The surviving sepsis
campaign recommends a 30 cc/kg bolus in the first 3 h
of resuscitation [2]. Further fluid therapy is guided by
monitoring various hemodynamic metrics such as the
central venous pressure or the mean arterial pressure.
The mean amount of fluids given in our cohort within
the first 6 h was 1.75 l. There was however a statistically
significant difference in fluid resuscitation between the
hypotensive and normotensive group. This discrepancy
is probably stemming from the prejudice that hypotensive
patients are sicker. However, EGDT and SSC recommend
aggressive hydration to both severe sepsis and septic shock
regardless of blood pressure on presentation. Early antibi-
otics have been shown to improve survival in septic pa-
tients [9]. The mean time to antibiotic in our study was
3.43 h with the majority (87.6 %) of antibiotics started in
the emergency department. It is important to note that at
the time the study was conducted, our institution did not
follow yet a standardized protocol-based approach to sep-
sis management, which would explain why most sepsis re-
suscitation goals were not met.
According to the literature, the most common infec-
tion sites in septic patients are the respiratory and geni-
tourinary systems as well intra-abdominal surgical
infections and indwelling catheters [5]. The most com-
mon focus of infection in our population was the genito-
urinary system with Gram-negative organisms being the
most predominant culprits. This is in accordance with a
previous study done in our institution looking at
bacteremia in febrile neutropenia patients that showed
the growing incidence of Gram-negative organisms [10].
Septic shock is one of the leaders in mortality now-
adays, but with early recognition and treatment, we have
seen an improvement in septic shock mortality [2]. The
mortality from septic shock was found to be as high as
46 % in the original EGDT control group, but the imple-
mentation of protocols aiming at early identification and
aggressive care has lead to an improved survival, and
nowadays the mortality from septic shock ranges be-
tween 20 and 30 % [1, 2, 11]. To the best of our know-
ledge, there is one study that looked at sepsis and its toll
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of a 6-h resuscitation bundle on sepsis outcome in a
Saudi Arabian intensive care unit and found a reduction
in mortality in septic patients from 31 to 21 % [12]. In
our cohort, the hospital mortality was 30.9 % and the
28-day mortality was 20.6 %. It was interesting to note
that there was no significant mortality difference be-
tween the normotensive and hypotensive patients at
presentation.
There are a limited amount of ICU beds at our institu-
tion. Very often, patients requiring ICU stay tend to re-
main in the ED for a prolonged time until a bed is
available. Should these patients improve during their ED
stay, they are downgraded to a GPU bed. This in part
explains our long ED length of stay and our high GPU
admission rate. Our GPU beds are not equipped with
continuous monitoring. Vital signs are taken every 4–
6 h. Vasopressors, antibiotics, and non-invasive ventila-
tion can be initiated on the GPU. Further invasive
hemodynamic monitoring (CVP, arterial lines) occurs in
the critical care units. Of all the patients who were ad-
mitted to the GPU, 10 passed away. They were stepped
up to an ICU bed and eight of them were successfully
moved to the MICU. The two remaining patients passed
away on the wards after their families requested to make
them comfort care. Overall, patients admitted to the
ICU had a greater mortality, and this can be explained
by the fact that sicker patients are usually admitted to
critical care units.
The SIRS criteria were initially proposed as a screen-
ing method to rapidly flag possible septic patients, as
sepsis is defined as having 2 or more SIRS criteria in the
setting of a presumed or documented infection. Even
though they were sensitive, SIRS criteria were not spe-
cific and did not correlate with mortality [13]. Owing to
the fact that our study was a retrospective one, we se-
lected patients based on their discharge diagnosis and
wanted to look at the value of the SIRS criteria at pres-
entation. It is interesting that in our study, 27 % of pa-
tients who presented with less than 2 SIRS criteria died
within their hospital stay. Emergency physicians should
be aware of this and should maintain a high level of sus-
picion when caring for septic patients presenting with
normal vital signs.
Limitations
This is a retrospective study done in a single emergency
department, and as such, our study has many limita-
tions. Some of the patients did not have repeat vitals at
6 h, and lactate was not drawn on all patients as our in-
stitution began measuring lactate on septic patients
fairly recently. Our sample size is small and there was a
significant amount of patients who were lost to follow-
up. Furthermore, information regarding initial EDdisposition or whether patients were stepped up to an
ICU level bed was not available. This can be explained
by our institution’s use of paper-based medical records
at the time of the study, which might have lead to the
loss of some patient information.
Conclusions
This is the first study looking at an in-depth analysis of
sepsis in the Middle Eastern population and examining
the overall management of septic patients and their in-
hospital mortality in a single tertiary care center in
Beirut, Lebanon, prior to the initiation of a protocol-
based approach. Although our mortality rate was in the
range of the Western world, it will be very interesting to
see the effect of sepsis treatment bundles advocating for
early recognition, aggressive hydration, and early antibi-
otics on sepsis-related mortality.
We hope that it will stimulate further prospective
studies on sepsis in the Middle East and other develop-
ing countries with limited healthcare resources.
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